| # | Title | Journal | Year | Citations |
|---|
| 1 | [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial | Lancet, The | 2021 | 552 |
| 2 | Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma | Clinical Cancer Research | 2017 | 192 |
| 3 | Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Small Cell Lung Cancer | Journal of Thoracic Oncology | 2017 | 122 |
| 4 | Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment | Journal of Cancer Survivorship | 2018 | 111 |
| 5 | Primary treatment of the prostate improves local palliation in men who ultimately develop castrate‐resistant prostate cancer | BJU International | 2013 | 101 |
| 6 | Immigrants' perceptions of the quality of their cancer care: an Australian comparative study, identifying potentially modifiable factors | Annals of Oncology | 2014 | 81 |
| 7 | The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy | Clinical Colorectal Cancer | 2016 | 73 |
| 8 | Oxidative stress in prostate cancer patients: A systematic review of case control studies | Prostate International | 2016 | 63 |
| 9 | Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis | BMC Cancer | 2018 | 59 |
| 10 | Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer | Cancer Letters | 2014 | 54 |
| 11 | Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies | International Journal of Molecular Sciences | 2016 | 50 |
| 12 | Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin | Journal of Circulating Biomarkers | 2018 | 47 |
| 13 | Migrant Health in Cancer: Outcome Disparities and the Determinant Role of Migrant-Specific Variables | Oncologist | 2015 | 46 |
| 14 | Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer | Critical Reviews in Oncology/Hematology | 2015 | 36 |
| 15 | Predictive and prognostic value of circulating tumor cell detection in lung cancer: A clinician's perspective | Critical Reviews in Oncology/Hematology | 2015 | 33 |
| 16 | New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use | International Journal of Cancer | 2014 | 31 |
| 17 | MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response | PLoS ONE | 2016 | 28 |
| 18 | Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer | Supportive Care in Cancer | 2016 | 27 |
| 19 | Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer | PLoS ONE | 2018 | 24 |
| 20 | CTC-mRNA (AR-V7) Analysis from Blood Samples—Impact of Blood Collection Tube and Storage Time | International Journal of Molecular Sciences | 2017 | 21 |
| 21 | Metabolic information on staging FDG-PET–CT as a prognostic tool in the evaluation of 97 patients with gastric cancer | Annals of Nuclear Medicine | 2014 | 20 |
| 22 | Using generalized estimating equations and extensions in randomized trials with missing longitudinal patient reported outcome data | Psycho-Oncology | 2018 | 20 |
| 23 | First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies | Investigational New Drugs | 2021 | 20 |
| 24 | TEPAPA: a novel in silico feature learning pipeline for mining prognostic and associative factors from text-based electronic medical records | Scientific Reports | 2017 | 19 |
| 25 | Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study | International Journal of Gynecological Cancer | 2007 | 17 |
| 26 | Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability | Cells | 2020 | 17 |
| 27 | The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors | Journal of Cancer Survivorship | 2022 | 16 |
| 28 | Traditional Oriental Herbal Medicine and Natural Killer Cells for Cancer Patients: A Systematic Review and Meta-analysis | Phytotherapy Research | 2017 | 15 |
| 29 | Early Postoperative Low Expression of RAD50 in Rectal Cancer Patients Associates with Disease-Free Survival | Cancers | 2017 | 12 |
| 30 | Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response | Oncologist | 2021 | 12 |
| 31 | Association between ribociclib and changes in creatinine in patients with hormone receptor positive metastatic breast cancer | Internal Medicine Journal | 2019 | 10 |
| 32 | Aberrant Expression of RAD52, Its Prognostic Impact in Rectal Cancer and Association with Poor Survival of Patients | International Journal of Molecular Sciences | 2020 | 10 |
| 33 | Ring a ring o'roses, a patient with Kaposi's? Pazopanib, pazopanib, it might go away . Mediterranean (classic) Kaposi sarcoma responds to the tyrosine kinase inhibitor pazopanib after multiple lines of standard therapy | Clinical and Experimental Dermatology | 2018 | 7 |
| 34 | Assessing outcomes of cancer care: Lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996-July 2000 | Journal of Medical Imaging and Radiation Oncology | 2004 | 6 |
| 35 | Imatinib in neurofibromatosis type 2 | BMJ Case Reports | 2013 | 6 |
| 36 | Small HER2-Positive Breast Cancer: Should Size Affect Adjuvant Treatment? | Clinical Breast Cancer | 2015 | 6 |
| 37 | Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy | Annals of Nuclear Medicine | 2017 | 5 |
| 38 | Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centres | Internal Medicine Journal | 2017 | 5 |
| 39 | Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence-based benchmark for cancer care | Asia-Pacific Journal of Clinical Oncology | 2015 | 4 |
| 40 | The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy | Acta Oncológica | 2020 | 3 |
| 41 | Prognostic Impact of TP53 Mutations and Tumor Mutational Load in Colorectal Cancer | Gastrointestinal Disorders | 2022 | 3 |
| 42 | A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular Tumour | Case Reports in Oncology | 0 | 3 |
| 43 | The Centre for Oncology Education and Research Translation (CONCERT) Biobank | Open Journal of Bioresources | 2015 | 2 |
| 44 | Dynamic Contrast-enhanced Magnetic Resonance Imaging Evaluation of Whole Tumour Perfusion Heterogeneity Predicts Distant Disease-free Survival in Locally Advanced Rectal Cancer | Clinical Oncology | 2022 | 2 |
| 45 | Feasibility of virtual reality‐delivered pain psychology therapy for cancer‐related neuropathic pain: a pilot randomised controlled trial | Anaesthesia | 2023 | 2 |
| 46 | Influence of EGFR mutation status and PD‐L1 expression in stage III unresectable non‐small cell lung cancer treated with chemoradiation and consolidation durvalumab | Asia-Pacific Journal of Clinical Oncology | 0 | 2 |
| 47 | 14. Upregulated PLK1 expression confers radiation resistance and poor patient survival outcomes in rectal cancer | Pathology | 2015 | 1 |
| 48 | PEGylated Liposomal Doxorubicin Rechallenge following Doxorubicin-induced Pancreatitis | Current Problems in Cancer Case Reports | 2020 | 1 |
| 49 | Menetrier’s disease exacerbating ulcerative colitis and relieved by gastrectomy | BMJ Open Gastroenterology | 2021 | 1 |
| 50 | Acute Retrograde Amnesia as First Presentation in Terminal Metastatic Cancer | Journal of Palliative Medicine | 2006 | 0 |
